Ankara University
Question
Asked 2 March 2021
How to avoid ulcers in s.c. injected tumors ?
Recently, we have injected s.c. B16F10 tumor cells in BL/6 mice. At around 12-15th day some animals showed ulcerations in tumors , with a big hole in the middle (it looks like a volcano). We have also observed this problem in MC38 and EG7 tumors. This did not happen to us so often until now. Any suggestion or personal experience that helps us to resolve this issue will be really appreciated. Thanks in advance.
Most recent answer
Try decreasing the number injected vital cells
All Answers (5)
Centenary Institute
Yeah, it is actually not rare. We just use less cells and/or with matrix. This paper might give you some clues.
Int J Exp Pathol. 2015 Apr; 96(2): 73–80. Published online 2015 Feb 9. doi: 10.1111/iep.12114PMCID: PMC4459798PMID: 25664478
Behaviour of four different B16 murine melanoma cell sublines: C57BL/6J skin
By the way, which B6 was used in your experiments? B16F10 (ATCC® CCL-6475™) is from a C57BL/6J mouse. Sometimes, 6J and 6N are very different.
Good luck
National Center for Biotechnology (CNB)
Thank you for your answer. I will read the papers that you mention.
But this problem is something that is recently happening, and the tumor cell lines come from old frozen vials.
Centre for Cancer Biology
For an injection of 1x10e6 B16F10 we found day 12-14 there is occasionally some ulceratiin of tumours but it also when we reach the ethical limits of tumour size and the end of the experiment. This has been the case for these tumours for the last 10 years in the lab even with fresh, newly sourced cells vs old cells frozen for years. If you want to take them out longer then use less cells to start with.
National Center for Biotechnology (CNB)
Thank you Michaelia for your suggestions, we usually inject 0,2x106B16F10 cells and we end the experiment at day 20. Perhaps we should change the initial tumor cells dose and finish the experiment before .
Similar questions and discussions
Related Publications
When mice are used in studies where wasting and death are potential complications, practical, rapid, and noninvasive methods for assessing health status and establishing endpoints are needed. Tumor growth studies are often very challenging as the growth of the tumor may mask one of the more commonly used endpoints - loss of weight. In 1999, body co...
Thesis (doctoral)--Faculte de Médecine et de Pharmacie de Lyon, 1942.